Micro
Emerging
Active
DAFNA Capital sells AXGN shares amid stock surge
New narrative with limited coverage — still forming.
Score
0.2
Velocity
▲ 0.0
Articles
4
Sources
1
Sentiment Timeline
Sector Performance
Stock Performance
Event Timeline
Related Articles
What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge
Nasdaq
·
May 24, 2026
Hedge Fund Delta Global Exited Its Stake in Abercrombie & Fitch Stock. Here's What That …
Nasdaq
·
May 16, 2026
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth
Nasdaq
·
Mar 22, 2026
🤖
AI Overview
What happened: DAFNA Capital Management sold 265,456 shares of Axogen (AXGN) in Q4 2021, with an estimated transaction value of $6.53 million, amid a 71% stock surge and 20% revenue growth. The sale reduced their quarter-end position value by $2.36 million.
Market impact: The sell-off by DAFNA Capital could signal a shift in sentiment towards AXGN, potentially impacting the medical technology sector. This action might influence other investors, leading to a decrease in demand for AXGN shares and a possible correction in its stock price.
What to watch next: AXGN's Q1 2022 earnings report on May 5, 2022, will provide insights into the company's financial health and growth prospects. Additionally, any further significant sell-offs or buybacks by other hedge funds in the medical technology sector will indicate the broader trend for AXGN and similar stocks.
Market impact: The sell-off by DAFNA Capital could signal a shift in sentiment towards AXGN, potentially impacting the medical technology sector. This action might influence other investors, leading to a decrease in demand for AXGN shares and a possible correction in its stock price.
What to watch next: AXGN's Q1 2022 earnings report on May 5, 2022, will provide insights into the company's financial health and growth prospects. Additionally, any further significant sell-offs or buybacks by other hedge funds in the medical technology sector will indicate the broader trend for AXGN and similar stocks.
AI Overview as of May 30, 2026
Timeline
First SeenMar 22, 2026
Last UpdatedMar 22, 2026